Following market traction, the science-led supplements raised pre-seed funding to expand their product range.WHO: Founded in 2024 by nutrition scientist Alice van der Schoot, DITTO Daily developed the Cycle Supplement to comprehensively target both the mental and physical challenges of the menstrual cycle. The supplement is formulated with 10 carefully selected ingredients with the strongest clinical evidence for menstrual cycle symptom relief. It features an innovative nutrient delivery biotechnology, "beadlet-in-oil," designed to enhance nutrient absorption. WHY: The investment will support continued scientific research, solution-oriented innovation, and channel expansion.IN THEIR OWN WORDS: Alice van der Schoot, founder of DITTO Daily, said, "For too long, there has been a huge disconnect between what science understands and the solutions available to those suffering from cycle-related symptoms. Too many are given outdated advice or left to navigate trial and error with ineffective approaches."Camilla Dolan, General Partner at Eka Ventures, said, “Eka is thrilled to lead DITTO Daily’s pre-seed round, backing Alice’s vision to translate cutting-edge academic science into mainstream, efficacious products that improve women’s daily health from the inside. Early feedback and clinical results from DITTO Daily’s first product, Cycle supplement, demonstrates the unmet need in women’s health and the team’s ability to deliver fast, evidence-based impact.”DETAILS:DITTO Daily raised £1.35 million ($1.57 million) in pre-seed funding led by Eka Ventures, with participation from notable investors including Jean-Baptise Wautier.